PB LIVE webinar - Collagen supports joint health: Asian interest increases
Start: 15/06/2022 - 08:00 (CEST)
End: 15/06/2022 - 09:00 (CEST)
Wednesday June 15, 2022, 2 PM SGT (8 AM CET).
Joint health is a key concern for middle-aged consumers. Collagen peptides are gaining recognition as a joint health ingredient. While Asian consumers are familiar with collagen peptides for their skin health benefits, their joint health potential are a market opportunity to explore.
• Unique clinical evidence: intake of SOLUGEL® collagen peptides reduces joint pain among active middle-aged adults
• Collagen trends in Asia
• Scientific landscape of collagen peptides in joint health
• New collagen peptides products and applications capitalizing on joint health
Make sure you register before the event starts, to enjoy free access.
Yingying Wu is the Global Product Manager Health & Nutrition at PB Leiner. She holds a Master of Science in Marketing Management and a Bachelor of Science in Applied Chemistry. She has 10 years of experience in the food, health and nutrition, and the ingredients industry. She has in-depth knowledge about the market and consumer trends, evolution, and innovation of the collagen peptides industry. She supports customers on co-innovation projects in the health & nutrition markets and converts opportunities into business.
Reyhan Nergiz-Unal is Health and Nutrition Science Lead at PB Leiner. She holds a doctorate degree (PhD) in Medical Biochemistry from the University of Maastricht and a Master of Science (MSc) in Food and Nutritional Sciences. Reyhan started her career as a nutritionist and dietician, after which she developed a strong experience in human nutrition and scientific research. She has been Principal Scientist, Associate Professor, and Head of the Research Laboratories at Hacettepe University for several years before joining PB Leiner. Next to her work at PB Leiner, she is currently also lecturing as adjunct professor at the Istanbul Kent University, focusing on the fields of human metabolism and nutritional biochemistry.
SOLUGEL® reduces joint pain in active middle-aged adults
Did you know that globally 93% of middle-aged adults are concerned about joint health, and 2 out of 3 indicate experiencing moderate to severe joint pain? At the same time, people in this age group are also more physically active than ever, and see exercise as a vital means of maintaining their overall health and fitness.
Studies have shown that collagen can reduce joint pain among those suffering from conditions such as osteoarthritis as well as joint stability problems, injured joints, or exercise-induced issues. However, no previous research had proven its long-term impact on both joint pain and everyday activities in the healthy and active middle-aged population.
In a unique study commissioned by PB Leiner, Florida State University found that SOLUGEL® collagen peptides have the ability to help the growing number of healthy and active middle-aged people struggling with joint pain.
To learn more, download our brochure!
To the brochure